Pro Medicus, Ltd. · ASX:PME

Pro Medicus — Macquarie Conference 2019

38 slides from Pro Medicus's conference presentation, May 2, 2019

  1. Slide 1: Investor Presentation May 2019

    OUR SUPPORT. YOUR SUCCESS. INVESTOR PRESENTATION MAY 2019 Lf VISAGE IMAGING’

  2. Slide 2: Pro Medicus (ASX:PME)

    VV PRO MEDICUS (ASX:PME) f Healthcare IT company specializing in Enterprise Imaging and ia Radiology Information System (RIS) software. Leading edge products, growing global presence. @ VISAGE RIS Berlin GmbH @) EU HO/R&D Gp) U.S. HO a ; San Diego CA =) - = GROUP HQ =n N Melbourne AUS od eS © Th A p

  3. Slide 3: Visage Product Suite

    VISAGE RIS ©) ASX:PME pro+medicus.net @B VISAGE? Pd | OEM VISAGE 7 OEM PRODUCT SUITE prosmedicu % ners ie, Visace IMAGING:

  4. Slide 4: Visage RIS

    @ VISAGERIS TECHNOLOGIST DOCTOR TRANSCRIPTIONIST. SEARCH CLAIMING — SETUP. Recent|¥ Dr RSimpson |v /+ ‘Appointments Northern Book ‘Visage General Hospital 4 Tue, 17-0cr201 MTP” @ Patient © Procedure [Cancelled Blocked Visage Xray ~ Visage US Room ~ Visage US Room 2 ~ ssn (Visage US Room3 + Visage Ma

  5. Slide 5: Visage RIS contracts

    6 A VV VISAGE RIS WP Long term (5 year) contracts with Primary Healthcare and @ VISAGE RIS |-MED, the 2 biggest radiology providers in AUS Combined additional revenue of $4.4M pa once fully deployed cay saa Ei Biebeenek prehensive care, Uncompromising auality, Rollouts progressing well Potential ups

  6. Slide 6: Leading Edge Platform

    LEADING EDGE PLATFORM Visage 7.0 continues to be #1 in Speed, Functionality and Scalability. SPEED FUNCTIONALITY SCALABILITY proemedicus & VISAGE TMAGING'

  7. Slide 7: North American Market

    ‘<hy > NORTH AMERICAN MARKET VISAGE IMAGING’ ¢ PACS market estimated at > US $2B pa and growing * Expanding into Enterprise Imaging ¢ Paradigm shift to modular, best-of-breed approach ¢ Market fragmented — in process of consolidating ¢ VISAGE 7? - proven, market leading technology ¢ Rapidly growing

  8. Slide 8: Massive Data Explosion

    MASSIVE DATA EXPLOSION ¢ High density Multi-slice CT - 10,000+ images ¢ HD Breast Tomosynthesis - 6 GB+ ¢ (Optoacoustic breast ultrasound - 10+ GB ¢ Total Body PET Scan - 10+ GB ¢ 7T MRI - much larger than 3T & founsupront your success VISAGE IMAGING’ 8

  9. Slide 9: Electronic Health Record (EHR)

    ELECTRONIC HEALTH RECORD (EHR) ¢ Mandated in US Hospitals by end of 2018 * Consolidates all hospitals data - clinical and financial ° 90% of EHR is imaging data (by volume) ¢ Driving adoption of VNA ¢ Need fora single viewer for all images prosmedicu & ‘OUR SUPPORT. YOUR SUCCESS. VISAGE. TMAGING’ 9

  10. Slide 10: Solution: Visage 7 Streaming Technology

    y vv SOLUTION: * & \~ VISAGE 7? Streaming Technology v. BACKEND RENDER SERVER SERVER RADIOLOGIST/CLINICIAN MODALITIES — = os FL, Vy A prosmedicus 4% founsupront your success VISAGE IMAGING’ 10

  11. Slide 11: For personal use only

    For personal use only • • • • • • •

  12. Slide 12: Exam (Transaction) Revenue

    EXAM (TRANSACTION) REVENUE ¢ Recurring in nature ° Increased by 31% from 2H18 to 1H19 * Growth to continue in FY 2019 onwards (Mayo, Yale & others) * Growth from existing clients (organic and M&A) plus new clients ¢ Step up in FY 2020 with Partners Healthcare and Duke Health * Further upside with ad

  13. Slide 13: Professional Services

    A VV PROFESSIONAL SERVICES v ¢ Project planning, training & implementation -—————— [ol * Revenue spread over the length of the contract Q A - new accounting standards (AASB 15) i ° Recurring in nature ~ 10% contract value oo i } e Will decrease as a % of total revenue as exam 0 g (transaction) reven

  14. Slide 14: HY 2019 Revenue Split

    HY 2019 Revenue Split 1H v 2H Revenue split - Reinstated for AASB 15 $30,000,000 CExam/licence revenue*** CASupport/baseline revenue*** Capital revenue (net of hardware) Professional Services (new revenue standard) *** ***Recurring revenue $25,000,000 $2,649,000 $20,000,000 $2,678,000 $15,000,000 $9

  15. Slide 15: Operating Leverage

    OPERATING LEVERAGE ¢ Highly scalable offering ed * No capex (HW) - SW only model S ° Training & Installation - charged as professional | services s ¢ Relatively fixed cost base * High operating leverage ¢ Margin continues to grow as footprint increases te $$$ prosmedicus | 4% founsupront your succes

  16. Slide 16: Margin Expansion

    MARGIN EXPANSION - | EBIT Margins a es FY-14 FY-15 FY-16 FY-17 FY-18 founsupront your success VISAGE IMAGING’

  17. Slide 17: Year in Review

    A YY IN REVIEW é YEAR TO DATE _— _ = Carle = PARTNERS ep VA @ sce, fouteraty gyno. ae NewHaven =| (C__ >) $5M/? $27M/ als $4M/ $14M/ RY Heaith years 7 years $3M 5 years 7 years New New German Govt. Hospital VISN23 New On/Ahead Strong Contract Contract Contract Extension Contract Renewal Contract of

  18. Slide 18: Duke Health

    DUKE HEALTH * 7year- $14M deal, transaction-based licensing model ¢ Largest health system in North Carolina ¢ Ranked in the top 20 best hospitals in the U.S. ¢ Visage 7 to be implemented across all of Duke's radiology departments * Transaction-based model with potential upside e Adds to PME's growin

  19. Slide 19: Partners Healthcare

    PARTNERS HEALTHCARE Largest health system in Massachusetts Massachusetts General Hospital ranked (#4) and Brigham and Women's Hospital (#20) best hospital in US Top two teaching hospitals for Harvard Medical School Leader in biomedical and data science research — renowned MGH & BWH Center for Clinic

  20. Slide 20: Partners Healthcare (cont.)

    PARTNERS HEALTHCARE (cont. ) ¢ 7-year, $27M deal, transaction-based licensing model ¢ Largest contract in the history of PME ¢ VISAGE ? cornerstone of the Partners Radiology Enterprise Platform (PREP) ¢ Transformational - a key component of Partners 2.0 initiative prosmedicu % ners ie, Visace IMAGIN

  21. Slide 21: Partners Healthcare (cont.)

    4 , VY PARTNERS HEALTHCARE (cont.) Phase 1 ¢ Massachusetts General Hospital and Brigham and v Women's Hospital . ¢ Underway, with Go-Live planned for late Q4 FY19 y Phase 2 ° Other hospitals in Partners HealthCare network 7 ¢ |mplementation following completion of Phase 1 wN X i & cons VISAGE TMAGIN

  22. Slide 22: Other Sales

    A , VY OTHER SALES Carle Foundation - regional health system in Urbana IL 95M - 7 year transaction based deal VISN 23 - 5 year contract renewal (Feb 2019) Combined - deals worth $9M over 7 years prosmedicus | 4% founsupront your success VISAGE IMAGING’ 22

  23. Slide 23: Implementations

    4 VV IMPLEMENTATIONS On/Ahead Continues Completed under 25% of Continues iD of schedule to deliver the industry norm to deliver All Implementations Fast Track Methodology Large Scale Projects Huge Savings to the Client I =) /)) Frees Up —)-— Staff Reduced Key Differentiator Barrier to Change Ability

  24. Slide 24: Visage - Proven ROI

    & y YY VISAGE - PROVEN ROI Visace IMAGING’ (© Significant IT & Unparalleled Increase in Greater Clinical i Infrastructure Savings Radiologist Efficiency Accuracy : A ea = . » f Improved Physician Delivers Superior y IL Engagement Value Proposition = ; : prosmedicus | 4% founsupront your success VISA

  25. Slide 25: Visage - Proven ROI - Clinical

    VISAGE — PROVEN ROI - CLINICAL ¢ Child presents with severe headaches ¢ (T: aneurysms requiring emergency intervention ¢ No time to wait for tech or 3D lab post-processing ¢ MRA/VRA performed on-the-fly in VISAGE 7 prosmedicu % medicus Vice IMAGING 25

  26. Slide 26: Visage

    <> VISAGE - a VISAGE IMAGING’ rr itt A GOES A f prosmedicus 4 ‘oun suPpoRT.vour sucess VISAGE TMAGING®

  27. Slide 27: Visage - Proven ROI - Financial

    os VISAGE - PROVEN ROI - FINANCIAL VISAGE TMAGING’ 4 Radiologist Productivity and Turn-Around Time Data Analytics Ly STAT exams - 30.4% Radiologist turn-around-time improvement (Enterprise) Turn Around Time and Exam Volume - Stroke Median Rad TAT (min) o Ee 3 ° > = o x wi . “ prosmedicus ) ‘un suppo

  28. Slide 28: Visage - Proven ROI - Financial

    4 % VV VISAGE - PROVEN ROI - FINANCIAL VISAGE TMAGING® : CT Utilisation Growth at Visage Customer Reading “Thins” - 23% Growth Sg @® ton @) 7000 v 6000 © 5000 e 4000 3000 oe = 7 @ 2000 g »_ 1000 — 0 prosmedicus 4% founsupront your success VISAGE IMAGING’ 28

  29. Slide 29: Growth Strategy

    7 vv GROWTH STRATEGY As Transaction growth from existing clients VA Expand footprint - © @) Gp) New clients J Vv © New product offerings for existing clients VA Extend to other A) 7 @ Se geographical markets =” 2 Co Leverage R&D capability to introduce next ti duct: fo generation products y & VISAGE

  30. Slide 30: New Products: Visage 7 Open Archive

    b VV NEW PRODUCTS y 1 VISAGE ? OPEN ARCHIVE ¢ Same highly scalable enterprise imaging (2) @ : platform used in VISAGE 7 Sp) ¢ Modular design - interoperable in complex environments ¢ — Enables Visage to offer choice of deconstructed or single vendor solutions ¢ Well placed for North American ) ® so

  31. Slide 31: Mercy

    4 VV MERCY VISAGE ? OPEN ARCHIVE ° $15M-7 year deal of ¢ Mercy to standardize on VISAGE 7 Open = Archive across its diagnostic imaging V business 4 y ( v ° Over 28M diagnostic imaging exams a migrated to VISAGE Open Archive 5 ) “ol ¢: A * Golive early 04 FY2019 re) © Once completed - one of the larg

  32. Slide 32: New Products: Enterprise Imaging

    VV NEW PRODUCTS ENTERPRISE IMAGING VISAGE 7 Al ¢ — Single viewer for ALLimages in the medical record (EMR) * — Radiology/Cardiology (DICOM format) ¢ Non-radiology- reflected light - hi-res photos & videos ENCOUNTER BASED MAGES ‘A ¢ VISAGE 7 technology ideally suited b ° Increases Visage value propos

  33. Slide 33: Enterprise Imaging

    <)> ENTERPRISE IMAGING prosmedicus ay VISAGE TMAGING’

  34. Slide 34: Prospects and Pipeline

    © Prospects At various stages Network Effect of the cycle From recent high profile wins e Opportunities < Increasing number cs Pipeline Robust coming to market In terms of quality and quantity of opportunities prosmedicus | % founsupront your success VISAGE IMAGING’ 34

  35. Slide 35: Artificial Intelligence

    s vv ARTIFICIAL INTELLIGENCE VISAGE ‘Al ¢ Healthcare imaging ideally suited to Al ¢ Visage well positioned to take advantage of this emerging technology ¢ Advanced image processing in © | @ healthcare is “in our DNA” ° ° VISAGE ? architecture based on GPU “~~ 4 e technology used in Al (6 4) 4 BS Si

  36. Slide 36: Artificial Intelligence (cont.)

    4 vv ARTIFICIAL INTELLIGENCE (cont. ) ¢ "In product” Al - automated high-end functions within VISAGE 7 VISAGE ‘Al @ / e VISAGE 7 Al single visualization — platform for both the clinical AND ® © research environments ¢ VISAGE 7 Al- Open platform enables oe integration of 3 party algorithms o' 2) 4) P

  37. Slide 37: For personal use only

    For personal use only • • • • • • • •

  38. Slide 38: Thank You

    % ‘AGE TMAGING’ THANK YOU > i _ < pd Ajuo esn feuosiecd 105

Pro Medicus — Macquarie Conference 2019 on 6ix